Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Has results × inavolisib × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 417 Bevacizumab 409 Carboplatin 356 Paclitaxel 310 Gemcitabine 304 pembrolizumab 295 Cisplatin 292 Docetaxel 267 Rituximab 262 Radiotherapy 253 Nivolumab 195 Fluorouracil 195 Dexamethasone 195 Doxorubicin 193 Oxaliplatin 181 Capecitabine 181 Erlotinib Hydrochloride 163 fludarabine phosphate 161 Etoposide 158 Pemetrexed 151 Cetuximab 151 Bortezomib 147 Leucovorin 144 Lenalidomide 144 Cytarabine 140 fludarabine 139 Irinotecan 139 Trastuzumab 138 Prednisone 132 Filgrastim 132

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04849364 2025-05-31

PERSEVERE

Hoosier Cancer Research Network

Phase 2 Terminated

52 enrolled 16 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡